معرفی
Kara Gibson serves as an Assistant Clinical Professor in the Department of Anesthesia at McMaster University. Despite her primary academic appointment in anesthesia, her scholarly activity is overwhelmingly concentrated in ophthalmology, with 20+ publications (2023-2025) focused on diabetic macular edema (DME) therapeutics and retinal imaging analysis.
Her research centers on evaluating faricimab—a dual Ang-2/VEGF-A inhibitor—in phase 3 clinical trials (YOSEMITE, RHINE, ALTIMETER) and real-world studies. Key interests include quantitative analysis of retinal fluid dynamics, hyperreflective foci, and hard exudates using optical coherence tomography (OCT), with emphasis on comparative efficacy against aflibercept and potential for extended dosing intervals. A secondary focus involves obstetric anesthesia, evidenced by her 2023 publication on COVID-19 ethical challenges in parturient care.
Analysis of her 15 most recent publications reveals consistent themes: faricimab demonstrates superior anatomical control (reduced intraretinal fluid, hyperreflective foci, and macular leakage) and durability compared to aflibercept, enabling extended dosing (Q16-20W). Her work bridges clinical trial data with real-world applicability, predominantly published in high-impact ophthalmology journals including Investigative Ophthalmology and Visual Science and Clinical and Experimental Ophthalmology.
Dr. Gibson maintains active collaborations with retinal research teams, evidenced by her contributions to multi-center trials. Her scholarly impact is reflected in Mendeley readership (27-53 readers per recent publication) and media coverage, though no formal awards or student mentorship details are documented.
